Should adjuvant treatments be escalated in node-positive HR+/HER2- patients achieving pCR and omitting axillary dissection?

Update your browser to view ScienceDirect correctly.

Your technical details and browser version:

Request ID: 942d0b812bd1cf9b-LAX IP: 47.97.18.252 UTC time: 2025-05-20T16:00:05+00:00 Browser: Mozilla/5.0 (X11; U; Linux x86_64; en-US; rv:1.9.1.4) Gecko/20091030 Gentoo Firefox/3.5.4

Comments (0)

No login
gif